Velindre Cancer Centre Revenue and Competitors

Cardiff, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Velindre Cancer Centre's estimated annual revenue is currently $86.1M per year.(i)
  • Velindre Cancer Centre's estimated revenue per employee is $297,000

Employee Data

  • Velindre Cancer Centre has 290 Employees.(i)
  • Velindre Cancer Centre grew their employee count by 5% last year.

Velindre Cancer Centre's People

NameTitleEmail/Phone
1
Senior Project Manager - TCSReveal Email/Phone
2
Advanced Nurse PractitionerReveal Email/Phone
3
Therapeutic RadiographerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M520%N/AN/A
#2
$37M1375%N/AN/A
#3
$16.5M68-16%N/AN/A
#4
$42.5M1434%N/AN/A
#5
$48.4M1636%N/AN/A
#6
$25.1M930%N/AN/A
#7
$8.6M4011%N/AN/A
#8
$234.2M6945%N/AN/A
#9
$85.5M28810%N/AN/A
#10
$24.8M927%N/AN/A
Add Company

What Is Velindre Cancer Centre?

Cancer Centre Velindre Road, Whitchurch, Cardiff, CF14 2TL We are a specialist cancer treatment centre located on the perimeter of Cardiff. We provide

keywords:N/A

N/A

Total Funding

290

Number of Employees

$86.1M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Velindre Cancer Centre News

2022-04-19 - Thousands of inquiries to service helping older people access vital insurance

... to find cover is Elaine Davies, 58, who signed up to a charity trek across Cuba to raise money for Velindre Cancer Centre in Cardiff.

2022-04-17 - South Gloucestershire mum's long walk after death of kind ...

Mum-of-two Katie and friend Fay decided to walk rom Katie's home in Old Down to the Velindre Cancer Centre, a distance of over 30 miles...

2022-04-17 - Cyclists complete epic ride from Cardiff to Edinburgh for ...

The ride was organised to raise vital funds for two South Wales-based charities, the Velindre Cancer Centre and LATCH, the Welsh children's...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M2919%N/A
#2
$79.3M3027%N/A
#3
$15M3029%N/A
#4
$126.3M30810%N/A
#5
$111.6M3115%N/A